Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05257408
Title Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Corcept Therapeutics

ovary epithelial cancer

ovarian serous carcinoma

peritoneal carcinoma

fallopian tube carcinoma



Nab-paclitaxel + Relacorilant

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.